Patent linkage is a regulatory scheme under which marketing approval of generic drugs isn’t granted until the expiration of original drug’s patent.
Evergreening is a extension of the period of patent protection (or patent linkage) by making use of various laws and regulatory system.
See the article below. It is very informative. It also mentions KORUS FTA.
Powered by ScribeFire.